Journal
SCIENCE
Volume 294, Issue 5548, Pages 1871-1875Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.294.5548.1871
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL53558, HL58464] Funding Source: Medline
- NIGMS NIH HHS [GM63130] Funding Source: Medline
Ask authors/readers for more resources
Prostaglandins and leukotrienes are potent eicosanoid lipid mediators derived from phospholipase-released arachidonic acid that are involved in numerous homeostatic biological functions and inflammation. They are generated by cyclooxygenase isozymes and 5-lipoxygenase, respectively, and their biosynthesis and actions are blocked by clinically relevant nonsteroidal anti-inflammatory drugs, the newer generation coxibs (selective inhibitors of cyclooxygenase-2), and Leukotriene modifiers. The prime mode of prostaglandin and Leukotriene action is through specific G protein-coupled receptors, many of which have been cloned recently, thus enabling specific receptor agonist and antagonist development Important insights into the mechanisms of inflammatory responses, pain, and fever have been gleaned from our current understanding of eicosanoid biology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available